[Agranulocytosis and metamizole]

Area of Science:

• Pharmacology
• Hematology

Context:

• Drug-induced agranulocytosis is a rare but serious adverse effect.
• Determining the exact cause of agranulocytosis can be challenging due to polypharmacy.

Purpose:

• To investigate the incidence and potential link between metamizole use and agranulocytosis.
• To compare the side-effect profile of metamizole with alternative medications.

Summary:

• A study of 78,000 patients identified 12 cases of drug- or allergy-induced agranulocytosis.
• A possible association was observed between metamizole and six cases, including two deaths.
• The incidence is comparable to literature reports, and alternative drugs do not show a definitively better safety profile.

Impact:

• Findings suggest no current reason to cease metamizole use, pending further research.
• Highlights the ongoing challenge of attributing causality in drug-induced agranulocytosis.
• Informs clinical practice regarding the risk-benefit assessment of metamizole.